期刊文献+

心力衰竭患者并发肺部感染的相关危险因素及治疗措施 被引量:11

Risk factors and treatment measures for pulmonary infections in heart failure patients
原文传递
导出
摘要 目的探讨心力衰竭患者并发肺部感染的相关危险因素及治疗措施,以降低肺部感染发生率。方法选择2008年2月-2011年7月医院收治的心力衰竭患者80例,根据并发感染情况,分为感染组10例与非感染组70例,两组均采用药物联合治疗,同时对两组相关资料进行调查。结果经过治疗后,非感染组临床有效率为97.5%,感染组有效率为95.0%,两组治疗效果均较好;肺部感染的发生与住院天数、年龄、曾经使用药物状况等因素密切相关(P<0.05)。结论肺部感染常见于心力衰竭住院患者,住院天数、年龄、曾经使用药物是重要的发病危险因素,针对肺部感染发生的危险因素应采取有效的治疗措施以降低肺部感染发生率。 OBJECTIVE To investigate the related risk factors and treatment of pulmonary infections in heart failure patients so as to take effective measures to reduce the incidence of pulmonary infections.METHODS A total of 80 heart failure patients with pulmonary infections from Feb 2008 to Jul 2011 in the hospital were selected,according to the status of concurrent infections,these patients were divided into 70 cases of the infection group,10 patients in non-infection group,all cases were given drugs combination therapy in both groups,the related data of the two groups were investigated.RESULTS After the treatment,the clinical effective rate of the non-infection group was 97.5%,95.0% in the infection group,both were with better treatment effect;the incidence of pulmonary infections was closely related to the hospitalization duration,the age,and the previous use of antibiotics(P0.05).CONCLUSION The pulmonary infections frequently occur in the heart failure patients,the hospitalization,age,and the previous use of antibiotics are the risk factors.It is necessary to take effective treatment measures to reduce the incidence of pulmonary infections.
作者 冯慧远
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第20期4471-4472,共2页 Chinese Journal of Nosocomiology
关键词 心力衰竭 肺部感染 危险因素 Heart failure Pulmonary infection Risk factors
  • 相关文献

参考文献8

二级参考文献24

共引文献2576

同被引文献74

  • 1Balami JS, Buchan AM. Complications of intracerebral haem-orrhage[J]. Lancet Neurol,2012,11 (1) : 101-118. 被引量:1
  • 2Chen YD, Li SJ,Sun FH,etal. Monitoring of medical com-plications after acute ischemic stroke in a neurological inten-sive care unit[J], Eur Neurol, 2011,66(4) :204-209. 被引量:1
  • 3Cazzola M,Page CP,Calzetta L,et al.Emerging anti-inflammatory strategics for chronic obstructive pulmonary disease[J].Eur Rcspir J,2012,40(3):724-741. 被引量:1
  • 4Akgiin KM,Crothcrs K,Pisani M.Epidcmiology and management of common pulmonary diseases in older persons[J].J Ucrontol A Biol Sci Med Sci,2012,67(3):276-291. 被引量:1
  • 5Ogeng′o JA,Gatonga PM,Olabu BO,et al.Pattern of congestive heart failure in a Kenyan paediatric population[J].Cardiovasc J Afr,2013,24(4):117-120. 被引量:1
  • 6Forfia PR,Vaidya A,Wiegers SE.Pulmonary heart disease:the heart-lung interaction and its impact on patient phenotypes[J].Pulm Circ,2013,3(1):5-19. 被引量:1
  • 7Butrous G.The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases[J].Glob Cardiol Sci Pract,2014(3):257-290. 被引量:1
  • 8Sikkel MB,Hayward C,MacLeod KT,et al.SERCA2agene therapy in heart failure:an anti-arrhythmic positive inotrope[J].Br J Pharmacol,2014,171(1):38-54. 被引量:1
  • 9Leli C.Utility of brain natriuretic peptide as prognostic marker in community-acquired pneumonia and chronic obstructive pulmonary disease exacerbation patients presenting to the emergency department[J].Infez Med,2011,19(4):235-240. 被引量:1
  • 10Sakamoto D,Sakamoto S,Kanda T.Validation of circulating BNP level>1000pg/ml in all-cause mortality:a retrospective study[J].J Int Med Res,2015,43(4):583-591. 被引量:1

引证文献11

二级引证文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部